Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: tablet Magnesium Glycinate 300 mg: 300 mg, orally once daily in the morning after food for 12 weeks.
Control Intervention1: No comparator: No comparator
Sponsors
Dr Sakthi balan
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male or female Type 2 DM patients treated with oral hypoglycemic agents, in the age group of 18-60 years. 2.HbA1C levels of the patients should be between 6.5 to 7.0% in the last 3 months. 3.Patients having low serum magnesium levels 4.Patient should have not participated in any other study during the past 3 months.
Exclusion criteria
Exclusion criteria: 1.Patients who are having other conditions contraindicating for magnesium supplementation. 2.Patients who are alcoholic, suffering from chronic diarrhoea and on treatment with diuretics within 4 weeks before study initiation. 3.Pregnant and lactating women. 4.Patients who are unable to sign informed consent or unable to comply with study procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the glycemic status (FBS, PPBS, HbA1c) among patients treated with oral hypoglycemic agents alone and oral hypoglycemic agents with magnesium glycinate supplementTimepoint: 4,8 and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| well being assessment by questionnaire.Timepoint: baseline and 12 weeks | — |
Countries
India
Contacts
Public ContactSakthi balanM
Sri Venkateshwaraa Medical College Hospital & research centre
Outcome results
None listed